Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosus

Rheumatology (Oxford). 2016 Nov;55(11):2085-2087. doi: 10.1093/rheumatology/kew267. Epub 2016 Jun 24.

Authors

Theofanis Karageorgas¹, Athanasios Zomas², Pinelopi Kazakou², Pelagia Katsimbri², Marina Mantzourani³, Dimitrios Boumpas²

Affiliations

¹ Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, University Hospital of Athens 'Attikon' [email protected].
² Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, University Hospital of Athens 'Attikon'.
³ 1st Department of Internal Medicine, University Hospital of Athens 'Laiko', Athens, Greece.

PMID: 27342142
DOI: 10.1093/rheumatology/kew267

No abstract available

Publication types

Case Reports

MeSH terms

Anemia, Hemolytic, Autoimmune / drug therapy*
Anemia, Hemolytic, Autoimmune / etiology
Antibodies, Monoclonal / administration & dosage*
Antibodies, Monoclonal, Humanized
Antineoplastic Agents / administration & dosage
Dose-Response Relationship, Drug
Female
Humans
Infusions, Intravenous
Lupus Erythematosus, Systemic / complications*
Young Adult

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
ofatumumab